2015
DOI: 10.1021/acschembio.5b00211
|View full text |Cite
|
Sign up to set email alerts
|

eZinCh-2: A Versatile, Genetically Encoded FRET Sensor for Cytosolic and Intraorganelle Zn2+ Imaging

Abstract: Zn2+ plays essential and diverse roles in numerous cellular processes. To get a better understanding of intracellular Zn2+ homeostasis and the putative signaling role of Zn2+, various fluorescent sensors have been developed that allow monitoring of Zn2+ concentrations in single living cells in real time. Thus far, two families of genetically encoded FRET-based Zn2+ sensors have been most widely applied, the eCALWY sensors developed by our group and the ZapCY sensors developed by Palmer and co-workers. Both hav… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
118
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 81 publications
(128 citation statements)
references
References 40 publications
10
118
0
Order By: Relevance
“…11) (Aper et al, 2016). The Zn 2+ levels obtained using BRET detection were similar to those previously determined using the eZinCh-2 FRET-sensor (Hessels et al, 2015;Hessels, Taylor, & Merkx, 2016), but BRET-based detection resulted in lower cell-to-cell variation in emission ratio because of the absence of background fluorescence. The BLZinCh sensors, thus, not only allow straightforward monitoring of intracellular Zn 2+ levels using a plate reader, but should also be very useful for all those imaging applications where laser excitation is undesirable, such as prolonged imaging, imaging in optogenetics, imaging in light-sensitive cells, and in vivo imaging.…”
Section: Bret/fret-sensors For Intracellular Measurementssupporting
confidence: 79%
See 1 more Smart Citation
“…11) (Aper et al, 2016). The Zn 2+ levels obtained using BRET detection were similar to those previously determined using the eZinCh-2 FRET-sensor (Hessels et al, 2015;Hessels, Taylor, & Merkx, 2016), but BRET-based detection resulted in lower cell-to-cell variation in emission ratio because of the absence of background fluorescence. The BLZinCh sensors, thus, not only allow straightforward monitoring of intracellular Zn 2+ levels using a plate reader, but should also be very useful for all those imaging applications where laser excitation is undesirable, such as prolonged imaging, imaging in optogenetics, imaging in light-sensitive cells, and in vivo imaging.…”
Section: Bret/fret-sensors For Intracellular Measurementssupporting
confidence: 79%
“…In contrast to the eCALWY sensors, eZinCh-2 does not contain distinct Zn 2+ -binding domains, but has a Zn 2+ -binding histidine and cysteine residue located on the surface of both Cerulean and Citrine, which are fused via a long, flexible linker (Fig. 9A) (Hessels et al, 2015). The coordination of one Zn 2+ ion in between the two histidines and two cysteines brings the two fluorescent domains close together, inducing a $5-fold increase of FRET.…”
Section: Bret/fret-sensors For Intracellular Measurementsmentioning
confidence: 99%
“…The eZinCh-2 FRET sensor does not contain distinct Zn 2+ binding domains but displays a Zn 2+ coordinating histidine and cysteine residue on the surface of both Cerulean and Citrine. 15 Together, these four residues allow the formation of a stable tetrahedral Zn 2+ complex, bringing both fluorescent domains closer together and inducing an increase in FRET. To minimize the perturbation of the FRET sensor properties as much as possible, we introduced the NLuc domain at the N-terminus of the Cerulean domain in both sensors.…”
Section: Resultsmentioning
confidence: 99%
“…5,15,17,22,23 In addition, red-shifted variants have been developed that allow multiparameter imaging together with the original CFP-YFP-based sensors, allowing simultaneous Zn 2+ imaging in different cellular compartments in the same cell. 5,15,24,25 …”
mentioning
confidence: 99%
“…Although raising controversies that remain to be resolved, this new information suggests that modulation of ZnT8 activity may provide an interesting new target for diabetes therapies which can be used in a personalized manner to treat the aetiological deficiency in carriers of risk alleles. [56]) and Vamp2-eZinCh2 (yellow, [61]). Modified from [27].…”
Section: Discussionmentioning
confidence: 99%